Thuret, Isabelle <br/><br/>
Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus.  [electronic resource] 

 -  AIDS (London, England)  Nov 2009 
 - 2364-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e328331a456  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anti-HIV Agents--therapeutic use<br/>Anti-Retroviral Agents--therapeutic use<br/>Darunavir<br/>Drug Resistance, Multiple, Viral<br/>Drug Therapy, Combination--methods<br/>Female<br/>France--epidemiology<br/>HIV Infections--drug therapy<br/>HIV-1<br/>Humans<br/>Male<br/>Nitriles<br/>Pyridazines--therapeutic use<br/>Pyrimidines<br/>Pyrrolidinones--therapeutic use<br/>Raltegravir Potassium<br/>Sulfonamides--therapeutic use<br/>Treatment Outcome<br/>Viral Load